Bacteriophage therapy
Ludwik Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences. (2021). IITD PAN Wrocław – About us . IITD PAN Wrocław. Retrieved 23 February 2021, from http://www.iitd.pan.wroc.pl/en/Institute/ Luong, T., Salabarria, A., Edwards, R., & Roach, D. (2020). Standardized bacteriophage purification for personalized phage therapy. Nature Protocols , 15 (9), 2867-2890. https://doi.org/10.1038/s41596-020- 0346-0 Matsuda, T., Freeman, T., Hilbert, D., Duff, M., Fuortes, M., Stapleton, P., & Daly, J. (2005). Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model. Surgery , 137 (6), 639-646. https://doi.org/10.1016/j.surg.2005.02.012 Mojica, F., Díez-Villaseñor, C., García-Martínez, J., & Soria, E. (2005). Intervening Sequences of Regularly Spaced Prokaryotic Repeats Derive from Foreign Genetic Elements. Journal of Molecular Evolution , 60 (2), 174-182. https://doi.org/10.1007/s00239-004-0046-3 Myelnikov, D. (2018). An Alternative Cure: The Adoption and Survival of Bacteriophage Therapy in the USSR, 1922 – 1955. Journal of The History of Medicine and Allied Sciences , 73 (4), 385-411. https://doi.org/10.1093/jhmas/jry024 Myelnikov, D. (2021). The History and Future of Bacteriophage Therapy [Zoom]. O’Hare, R. (2019). Tumour-targeting viruses hold hope for incurable brain cancers | Imperial News | Imperial College London . Imperial News. Retrieved 9 January 2021, from https://www.imperial.ac.uk/news/190727/tumour-targeting-viruses-hold-hope-incurable-brain/# Patey, O., McCallin, S., Mazure, H., Liddle, M., Smithyman, A., & Dublanchet, A. (2018). Clinical Indications and Compassionate Use of Phage Therapy: Personal Experience and Literature Review with a Focus on Osteoarticular Infections. Viruses , 11 (1), 18. https://doi.org/10.3390/v11010018 Phage therapy treats patient with drug-resistant bacterial infection . (2019) ScienceDaily. Retrieved 23 February 2021, from https://www.sciencedaily.com/releases/2019/05/190508134554.htm Pilleron, S., Soto ‐ Perez ‐ de ‐ Celis, E., Vignat, J., Ferlay, J., Soerjomataram, I., Bray, F., & Sarfati, D. (2020). Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050. International Journal of Cancer , 148 (3), 601-608. https://doi.org/10.1002/ijc.33232 Pirnay, J. (2020). Phage Therapy in the Year 2035. Frontiers in Microbiology , 11 . https://doi.org/10.3389/fmicb.2020.01171 Pirnay, J., De Vos, D., Verbeken, G., Merabishvili, M., Chanishvili, N., & Vaneechoutte, M. et al. (2010). The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure? Pharmaceutical Research , 28 (4), 934-937. https://doi.org/10.1007/s11095-010-0313-5 Pirnay, J., Verbeken, G., Ceyssens, P., Huys, I., De Vos, D., Ameloot, C., & Fauconnier, A. (2018). The Magistral Phage. Viruses , 10 (2), 64. https://doi.org/10.3390/v10020064 Pranjol, M., & Hajitou, A. (2015). Bacteriophage-Derived Vectors for Targeted Cancer Gene Therapy. Viruses , 7 (1), 268-284. https://doi.org/10.3390/v7010268 Prescott, L., Harley, J., & Klein, D. (1993). Microbiology . Wm. C. Brown Publishers. Przystal, J., Waramit, S., Pranjol, M., Yan, W., Chu, G., & Chongchai, A. et al. (2019). Efficacy of systemic temozolomide ‐ activated phage ‐ targeted gene therapy in human glioblastoma. EMBO Molecular Medicine , 11 (4). https://doi.org/10.15252/emmm.201708492 Salmond, G., & Fineran, P. (2015). A century of the phage: past, present and future. Nature Reviews Microbiology , 13 (12), 777-786. https://doi.org/10.1038/nrmicro3564 Sanmukh, S., & Felisbino, S. (2017). Bacteriophages in Cancer Biology and Therapies. Clinics in Oncology , 2 (1295). Schmidt, C. (2019a). Phage therapy’s latest makeover. Nature Biotechnology , 37 (6), 581-586. https://doi.org/10.1038/s41587-019-0133-z Schmidt, C. (2019b). Is Phage Therapy Here to Stay. Scientific American , 321 (5), 50-57. Schooley, R., Biswas, B., Gill, J., Hernandez-Morales, A., Lancaster, J., & Lessor, L. et al. (2017). Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails to Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection. Antimicrobial Agents and Chemotherapy , 61 (10). https://doi.org/10.1128/aac.00954-17 Shnayerson, M., & Plotkin, M. (2003). The Killers Within: The Deadly Rise of Drug-Resistant Bacteria . Back Bay.
274
Made with FlippingBook interactive PDF creator